Delivery Order SPE2DB20D3103-SPE2DB23FL9U8
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $16,226.87 firm-fixed-price delivery order is for the medication Betaseron 0.3 mg kits. The contract has an ultimate completion date of May 1, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA. The company holds a substantial...
- This federal contract award, valued at $18,798.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of BETASERON 0.3 MG KITS, a specialty medication. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price agreement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,601.72 firm fixed-price delivery order is for the supply of BETASERON 0.3 MG KITS, a specialty medication. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on September 12, 2025, for the supply of Betaseron 0.3 mg kits valued at $16,778.88. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply relationship with DLA, which procures medical supplies...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,266.27 by the Defense Logistics Agency on August 12, 2025, for the supply of Betaseron 0.3 mg kits. This firm fixed-price delivery order, which carries an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $78,747.09 firm fixed-price contract is for the supply of BETASERON 0.3 MG KITS, a specialty medication. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency awarded a delivery order valued at $22,385.72 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits under a firm fixed price contract. This competitively awarded, non-set-aside delivery order was executed on September 9, 2025, with an ultimate completion date of September 10, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,653.89, is for the supply of BETASERON 0.3 MG KITS, a medical product. The contract is a firm fixed-price delivery order type, with a completion date of February 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $12,990.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the procurement of BETASERON 0.3 MG KITS, a specialty pharmaceutical product. The contract has an ultimate completion date of June 25, 2024. There is no set-aside...
- This is a delivery order under contract SPE2DX15D1053|SPE2DX24F6NYE, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,907.36 firm fixed-price order is for BETASERON 0.3 MG KITS, a specialty pharmaceutical product, with a completion date of June 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FL9U8Delivery Order
This federal contract award, valued at $16,526.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Betaseron 0.3 mg kits, a specialty medication, with a completion date of December 22, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 12/21/22 |